Home › Products › Infectious Disease › Tafmune EM 10 Tablet
Tafmune EM 10 Tablet
Salt Composition: EMTRICITABINE,TENOFOVIR ALAFENAMIDE
- Manufacturer: CIPLA LTD
- Pack Size: 30 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 200MG+10MG
- Prescription Required
- Storage: Store Tafmune EM 10 Tablet below 30°C Protect the medicine from light and excessive moisture. Keep the medicine out of reach of children and pets If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
₹786.00₹981.56
Inclusive of all taxes
Product Introduction
Tafmune EM 10 Tablet contains the active ingredients Emtricitabine and tenofovir alafenamide. This is a combination antiretroviral medication. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents aged 12 years and above who weigh at least 35 kg. These medications work by slowing the spread of HIV in the body. Do not take Tafmune EM 10 Tablet if you are allergic to Emtricitabine, tenofovir alafenamide, or any of the other ingredients. Undergo regular HIV infection testing whilst using this medicine. Do not miss any doses or discontinue this medicine. Missing doses may increase your risk of acquiring HIV infection. This medicine does not protect against other sexually transmitted infections (STIs). Inform your physician if you have liver problems or liver disease, including hepatitis, kidney problems, or bone problems. Do not administer this medicine to children aged 11 years or under.
Uses
HIV infection
How it works
Emtricitabine and tenofovir alafenamide are nucleoside/nucleotide analog reverse transcriptase inhibitors, exhibiting their antiviral effect by competing with natural substrates and incorporating them into viral DNA, resulting in the termination of the DNA chain.
How to Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of Tafmune EM 10 Tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. If you have difficulty in swallowing the tablet whole, you can split it in half after consulting with your doctor.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Hepatitis B reactivation Increased risk of fracture Acute renal failure Common Nausea, vomiting
Expert Tips
Take the medicine exactly as prescribed — do not skip doses or stop without your doctor’s advice. Always take it with food to reduce nausea and vomiting. Do not take more than the recommended dose or change it without consulting your doctor. Continue using all HIV medications in your combination therapy as directed. Practice safe sex and avoid sharing needles to prevent spreading or worsening the infection.
References
- Descovy 200 mg/25 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. Published April 2022. Accessed May 20, 2023. https://www.medicines.org.uk/emc/product/2108/smpc
- Emtricitabine / Tenofovir Alafenamide - Patient | NIH. clinicalinfo.hiv.gov. Published February 27, 2023. Accessed May 20, 2023. https://clinicalinfo.hiv.gov/en/drugs/emtricitabine-tenofovir-alafenamide/patient#dr1
- KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
- Gilead Sciences, Inc., US Food & Drug Administration, [Revised on Sep 2017] [Accessed on 14th Aug 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208215s005lbl.pdf
Safety Advice
Pregnancy: Consult Your Doctor There is limited information on the use of Tafmune EM 10 Tablet during pregnancy. Inform your physician if you are pregnant or planning to get pregnant during the treatment.
Lungs: Consult Your Doctor It is unknown whether Tafmune EM 10 Tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
Breastfeeding: Unsafe Breastfeeding is not recommended in patients taking Tafmune EM 10 Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.